Jeffrey E. Cohen Sells 1,650 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) SVP Jeffrey E. Cohen sold 1,650 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the sale, the senior vice president now owns 5,185 shares of the company's stock, valued at approximately $1,622,905. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

HCA Healthcare Trading Down 2.9 %

NYSE:HCA traded down $9.47 on Monday, reaching $317.18. 1,232,309 shares of the stock traded hands, compared to its average volume of 1,097,358. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $335.83. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. The company's 50 day moving average is $321.04 and its 200-day moving average is $300.89. The firm has a market capitalization of $83.07 billion, a price-to-earnings ratio of 15.81, a price-to-earnings-growth ratio of 1.52 and a beta of 1.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts' consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company's quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.93 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 20.79 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.83%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare's payout ratio is 13.16%.

HCA Healthcare declared that its Board of Directors has authorized a share buyback plan on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its stock is undervalued.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $330.00 to $359.00 and gave the stock a "buy" rating in a research note on Friday, April 12th. Barclays raised their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an "overweight" rating in a research report on Monday, April 29th. Raymond James upped their price target on HCA Healthcare from $300.00 to $330.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 31st. Truist Financial raised their price target on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a "buy" rating in a research note on Wednesday, January 31st. Finally, TD Cowen dropped their target price on HCA Healthcare from $371.00 to $360.00 and set a "buy" rating for the company in a research report on Tuesday, April 30th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $317.00.

Hedge Funds Weigh In On HCA Healthcare

Hedge funds have recently modified their holdings of the business. Stone House Investment Management LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $25,000. Centerpoint Advisors LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $27,000. Atlantic Edge Private Wealth Management LLC purchased a new position in HCA Healthcare in the 4th quarter valued at about $27,000. LifeSteps Financial Inc. purchased a new position in shares of HCA Healthcare in the 1st quarter worth about $33,000. Finally, Bruce G. Allen Investments LLC acquired a new position in HCA Healthcare during the 4th quarter worth approximately $28,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.